Catalysts
HAE Stock Catalysts
Earnings · Growth Drivers · Events · AIQ Catalyst
HAEHaemonetics Corporation
Healthcare / Medical - Devices
Leader
Sector Leader
Latest quote
- Momentum91
- Value60
- Quality77
- Risk resilience67
- Sentiment—
Stock Catalyst Board
Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.
Upcoming reporting date available for this company.
Momentum 91/100 and sentiment — before the next covered event.
Updated Nov 18, 2026 · Sentiment 53.12%
Earnings History And Surprises
See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.
Earnings Expectations And Results
Compare what analysts expected with what the company reported across recent quarters.
| Report date | Fiscal period | EPS estimate | EPS actual | EPS surprise | Revenue estimate | Revenue actual |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | — | $1.29 | $1.35 | +4.7% | $345.15M | $357.76M |
| Aug 6, 2026 | — | $1.08 | $1.14 | +5.6% | $327.86M | $339.38M |
| May 7, 2026 | — | $1.28 | $1.29 | +0.8% | $336.83M | $346.35M |
| Feb 5, 2026 | — | $1.27 | $1.31 | +3.1% | $331.92M | $339M |
| Nov 6, 2025 | — | $1.12 | $1.27 | +13.4% | $329.77M | $327.32M |
| Aug 7, 2025 | — | $1.01 | $1.10 | +8.9% | $320.01M | $321.39M |
| May 8, 2025 | — | $1.22 | $1.24 | +1.6% | $312.47M | $330.6M |
| Feb 6, 2025 | — | $1.18 | $1.19 | +0.8% | $354.46M | $348.54M |
Analyst Forecast And Price Targets
Wall Street consensus, rating distribution, and the current 12-month target range.
Event Read
Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.
Current event setup
Next known earnings or reporting date.
Current analyst expectation for the upcoming report.
Current analyst expectation for the upcoming report.
News pressure around the setup.
Where event reaction would show up first.
Composite decision read before event confirmation.
Analyst context
News And Sentiment
Recent company coverage, scored where source sentiment is available.
Haemonetics Corporation (HAE) Gains on Strong Plasma Growth and Higher Guidance, Ariel Appreciation Fund Says
Ariel Investments, an investment management company, released its "Ariel Appreciation Fund" Q3 2026 investor letter. A copy of the letter can be downloaded here. Copy main article 1st para.
Related Links
HAE Catalysts FAQ
What are the next catalysts for HAE stock?
HAE's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.
What upcoming events could move HAE stock?
Upcoming events that could move HAE include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.
How could HAE's next earnings report affect the stock?
HAE's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.
What could drive HAE stock higher?
HAE could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.
What events could hurt HAE stock?
HAE could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.